Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novartis, ptc therapeutics and Huntington's Disease
Novartis In-Licenses PTCT's Huntington's Disease Drug for $2.9 Billion
Novartis will make an upfront payment of $1.0 billion to PTCT and the latter will also be eligible for up to $1.9 billion in development, regulatory and sales milestones. NVS will also share profits in the United States (40% PTC and 60% Novartis) and pay tiered royalties on ex-US sales.
Novartis in up to $2.9 billion licensing deal for PTC Therapeutics Huntington's disease drug
Swiss drugmaker Novartis will pay up to $2.9 billion for PTC Therapeutics' promising experimental drug for a neurological disorder called Huntington's disease, sending the U.S.-based biotech's shares up about 14% on Monday.
Novartis Pays Up to $2.9B in Huntington’s Deal With PTC
Monday’s agreement comes days after PTC discontinued the development of another asset, utreloxastat, due to disappointing Phase II data in amyotrophic lateral sclerosis.
3d
on MSN
New therapy for Huntington’s disease ‘may slow disease progression’
A patient in the UK has received a new therapy for Huntington’s disease, which experts hope could slow progression of the ...
Medpage Today on MSN
4d
Beta-Blockers Tied to Delayed Huntington's Disease Progression
The findings suggest that beta-blockers and other drugs that help restore balance to the autonomic nervous system may have ...
News Medical on MSN
2d
Heart medication may slow the progression of Huntington's disease
Research indicates β-blockers may reduce the risk of motor diagnosis and slow symptom progression in Huntington's disease, ...
FierceBiotech
4d
Novartis pays PTC $1B upfront for midphase Huntington's program, reestablishing itself in R&D race
Novartis is paying $1 billion upfront for global rights to PTC Therapeutics’ midphase Huntington's disease program, helping ...
Psychology Today
8d
How Huntington's Disease Helped Me Find My Magic
The Wicked Witch of the West and I have something in common: We both use our fatal flaws to our advantage—for her, her green ...
1d
Wave Life Sciences: Positioned for Growth with Promising Huntington’s Treatment and Strategic Advantages
Madison Elsaadi, an analyst from B.Riley Financial, reiterated the Buy rating on Wave Life Sciences (WVE – Research Report). The associated ...
Armed robbery in Revesby
1d
UCL Leads First Human Study for Huntington's Disease
The first patient has begun treatment on a global trial of a novel medication for Huntington's disease, led within the UK by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Novartis
PTC
Feedback